Does RUXOLITINIB Cause Hypoacusis? 157 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 157 reports of Hypoacusis have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.2% of all adverse event reports for RUXOLITINIB.
157
Reports of Hypoacusis with RUXOLITINIB
0.2%
of all RUXOLITINIB reports
7
Deaths
37
Hospitalizations
How Dangerous Is Hypoacusis From RUXOLITINIB?
Of the 157 reports, 7 (4.5%) resulted in death, 37 (23.6%) required hospitalization, and 4 (2.5%) were considered life-threatening.
Is Hypoacusis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 157 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Hypoacusis?
SACUBITRIL\VALSARTAN (2,345)
TOFACITINIB (1,535)
INSULIN GLARGINE (1,406)
APIXABAN (1,249)
PREGABALIN (1,152)
ETANERCEPT (1,109)
INSULIN LISPRO (1,100)
ADALIMUMAB (948)
LENALIDOMIDE (938)
PALBOCICLIB (890)
Which RUXOLITINIB Alternatives Have Lower Hypoacusis Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE